Abbott receives FDA approval for Lupron Depot
ABBOTT PARK, Ill. — The Food and Drug Administration has approved a new formulation of an injectable drug made by Abbott for prostate cancer.
Abbott announced Monday the approval of a 45-mg, six-month formulation of Lupron Depot (leuprolide acetate) for advanced prostate cancer. Previous formulations have allowed patients to receive the drug every month or every three or four months.
“Lupron Depot is an important treatment option for many patients with advanced prostate cancer,” Abbott VP global pharmaceutical development Eugene Sun said. “Approval of a new six-month formulation means that physicians and patients who have chosen Lupron Depot now have an additional treatment option.”
CVS/pharmacy introduces CARE 1on1
WOONSOCKET, R.I. — CVS/pharmacy has introduced its latest initiative, designed to underscore the role pharmacists play in managing ongoing medications for chronic illnesses, particularly when a patient starts a new medication.
Through CARE 1on1, CVS/pharmacy offers patients dedicated one-on-one time with a pharmacist to discuss savings, safety and side effects when their prescription is transferred or filled for the first time, the company said. How it works: When patients spend time with a CVS pharmacist through CARE 1on1, they will receive a personal review of their new ongoing medication filled at CVS/pharmacy and discuss ways to manage side effects, save money and stick to a medication routine.
The initiative follows recent CVS Caremark research that found that a pharmacist in a face-to-face setting is the most effective healthcare professional at encouraging patients to take medications as prescribed.
"Patients with chronic health issues like asthma, or chronic diseases like diabetes, often take more than one medication — each with its own set of directions and possible side effects," CVS Caremark VP pharmacy professional services Papatya Tankut said. "Our pharmacists are here to help patients get the most out of their medications once they leave the doctor’s office. Taking the time to speak to a pharmacist about your prescriptions can make a difference in the overall improvement of your health, particularly for those who are starting a new prescription."
More information about CARE1on1 can be found on CVS.com and in CVS/pharmacy stores nationwide.
Q&A: Perishable profits
Drug Store News spoke with Greg Tradup, category manager of perishable, supplies and foodservice at McLane Co., about how chain drug retailers successfully can operate in the growing perishable foods space.
Drug Store News: Why have fresh and frozen food become such an attractive category for chain drug retailers?
Greg Tradup: Drug stores need to find new ways to cater to the needs of their core female shoppers. The channel is becoming widely recognized more as a destination for grocery take-home items than c-store instant consumable items.
Take-home fresh and frozen foods offer a wide variety of options for meal preparation both at home and at the office, so it appeals to the drug store female core. The category also appeals to non-typical drug consumers who recognize the value of foregoing a trip to a large grocery store when the local drug store offers the same or similar items in a quick, convenient format.
DSN: How can McLane help drug retailers overcome barriers that traditionally have prevented the channel from entering the perishable category?
Tradup: McLane constantly is changing the cold-chain distribution dynamic. The traditional distribution solution of offering items that have a long shelf life and strong resistance to temperature changes has been replaced with high-turn, short-coded items like fresh milk, multitemperature produce, and cut fruits and salads tailored to meet specific retailer needs. Through our wide assortment of suppliers and long-term experience in the industry, McLane can tailor a program to meet just about any need a drug chain may have.
DSN: How does McLane help retailers stock the right assortment of products and keep that stock replenished?
Tradup: By maintaining one of the largest databases in the industry, McLane can manage top items in every category, watch for new and emerging trends, and get a jump on industry changes so our customers stay ahead of the competition. Through McLane’s proprietary ordering system, drug retailers can order short-coded (shelf life) product through us and receive product with plenty of shelf life remaining. In most cases, the retailer will receive product within a day or two after it’s delivered to McLane, providing the best dating possible.
McLane’s Smart Handheld Ordering System allows retailers to place their common orders, as well as keep on top of new items, new promotions and special offers our suppliers may be providing. The Smart Handheld also offers suggested orders based on previous ordering history, so that if a store forgets to order a common item, the system orders it for [that store].
DSN: What kind of space commitment is needed to maximize sales in this category?
Tradup: While optimal space commitment depends on the size, location and scope of the store, most stores need a section for open-air coolers, freezer doors and produce. It’s important to gain consumer confidence in a category that isn’t traditionally associated with the drug channel. Space should always be clutter-free and clean, as consumers won’t trust fresh or perishable items if they feel the products have been mishandled or contaminated.
For retailers with limited space, McLane has a range of attractive equipment solutions featuring cutting-edge “air-curtain” technology that enhances the presentation of fresh product and promotes impulse purchases.
DSN: What new segments of the category should drug retailers be considering?
Tradup: Offerings in fresh fruit and salads give the one-stop shopper another reason to skip the large grocery store in favor of a more convenient drug store. New changes in packaging allow for longer shelf life of fresh sandwiches — another key category. While not a consumable, another segment for retailers to keep an eye on is floral. Many drug chains have been expanding into fresh flowers and potted plants with promising results.